Sargent Investment Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,449
| Closed | -$211K | – | 244 |
|
|
2024
Q3 | $211K | Buy |
+1,449
| New | +$211K | 0.04% | 203 |
|
|
2024
Q1 | – | Sell |
-1,999
| Closed | -$272K | – | 211 |
|
|
2023
Q4 | $272K | Sell |
1,999
-158
| -7% | -$21.5K | 0.06% | 176 |
|
|
2023
Q3 | $264K | Hold |
2,157
| – | – | 0.06% | 164 |
|
|
2023
Q2 | $274K | Hold |
2,157
| – | – | 0.07% | 163 |
|
|
2023
Q1 | $280K | Hold |
2,157
| – | – | 0.07% | 157 |
|
|
2022
Q4 | $283K | Sell |
2,157
-100
| -4% | -$13.1K | 0.09% | 145 |
|
|
2022
Q3 | $276K | Hold |
2,257
| – | – | 0.09% | 141 |
|
|
2022
Q2 | $265K | Hold |
2,257
| – | – | 0.08% | 149 |
|
|
2022
Q1 | $294K | Buy |
2,257
+105
| +5% | +$13.7K | 0.07% | 152 |
|
|
2021
Q4 | $328K | Sell |
2,152
-25
| -1% | -$3.81K | 0.07% | 143 |
|
|
2021
Q3 | $352K | Buy |
2,177
+120
| +6% | +$19.4K | 0.09% | 138 |
|
|
2021
Q2 | $337K | Hold |
2,057
| – | – | 0.08% | 147 |
|
|
2021
Q1 | $310K | Buy |
2,057
+404
| +24% | +$60.9K | 0.08% | 149 |
|
|
2020
Q4 | $250K | Sell |
1,653
-50
| -3% | -$7.56K | 0.08% | 150 |
|
|
2020
Q3 | $231K | Hold |
1,703
| – | – | 0.08% | 144 |
|
|
2020
Q2 | $234K | Buy |
+1,703
| New | +$234K | 0.09% | 133 |
|
|
2019
Q3 | – | Sell |
-2,093
| Closed | -$228K | – | 148 |
|
|
2019
Q2 | $228K | Buy |
2,093
+138
| +7% | +$15K | 0.1% | 125 |
|
|
2019
Q1 | $219K | Buy |
+1,955
| New | +$219K | 0.11% | 124 |
|